SQL 6.6 (+0%)
US81734C1062Medical Diagnostics & ResearchDiagnostics & Research

SeqLL (SQL) Competitor Comparison

We are evaluating the key criteria listed to compare SeqLL (SQL) against its competitors in the Diagnostics & Research industry.

Performance 3 years - SQL ranking 56 / 58

These are the competitors of SeqLL in the industry Diagnostics & Research ranked by performance 3 years
1. Lantheus Holdings LNTH
317.31
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
135.98
4. Medpace Holdings MEDP
76.15
5. Heska HSKA
41.31
6. PerkinElmer PKI
21.19
7. Natera NTRA
16.41
8. Ortho Clinical Diagnostics Holdings OCDX
13.74
9. Icon ICLR
12.18
10. Quest Diagnostics DGX
5.41
11. Mettler-Toledo MTD
4.78
12. Thermo Fisher Scientific TMO
4.73
13. Danaher DHR
0.95
14. Waters WAT
-0.09
15. IQVIA Holdings IQV
-4.82
16. Agilent Technologies A
-6.62
17. Laboratory Corp of America Holdings LH
-9.4
18. Qiagen QGEN
-14.52
19. Myriad Genetics MYGN
-16.84
20. Bioventus BVS
-17.43
21. Syneos Health SYNH
-19.01
22. Olink Holding OLK
-22.2
23. IDEXX Laboratories IDXX
-22.87
24. Exact Sciences EXAS
-28.66
25. Sera Prognostics SERA
-32.68
26. Anixa Biosciences ANIX
-33.68
27. Sotera Health SHC
-39.97
28. DexCom DXCM
-50.01
29. CareDx CDNA
-52.9
30. National Research NRC
-52.96
31. Charles River Laboratories CRL
-53.81
32. Twist Bioscience TWST
-58.43
33. Illumina ILMN
-63.08
34. Neogen NEOG
-65.15
35. Enzo Biochem ENZ
-66.67
36. MaxCyte MXCT
-66.94
37. Global Cord Blood CO
-67.25
38. NeoGenomics NEO
-70.76
39. Psychemedics PMD
-72.03
40. Personalis PSNL
-73.14
41. Fulgent Genetics FLGT
-74.92
42. Interpace Biosciences IDXG
-77.64
43. bioAffinity Technologies BIAF
-78.33
44. Exagen XGN
-78.72
45. Biodesix BDSX
-80.44
46. Guardant Health GH
-80.75
47. MDxHealth MDXH
-83.54
48. Co-Diagnostics CODX
-86.25
49. Precipio PRPO
-87.59
50. Trinity Biotech TRIB
-88.52
51. Organovo Holdings ONVO
-89.19
52. Neuronetics STIM
-91.07
53. Pacific Biosciences of California PACB
-93.3
54. Inotiv NOTV
-93.71
55. DarioHealth DRIO
-93.77
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-95.75
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.